Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.

Panés J, Colombel JF, D'Haens GR, Schreiber S, Panaccione R, Peyrin-Biroulet L, Loftus EV Jr, Danese S, Tanida S, Okuyama Y, Louis E, Armuzzi A, Ferrante M, Vogelsang H, Hibi T, Watanabe M, Lefebvre J, Finney-Hayward T, Sanchez Gonzalez Y, Doan TT, Mostafa NM, Ikeda K, Xie W, Huang B, Petersson J, Kalabic J, Robinson AM, Sandborn WJ

Open source

DOI: 10.1053/j.gastro.2022.02.033
Published: 2022 Jun
Container: Gastroenterology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1053/j.gastro.2022.02.033,
  title = {Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.},
  author = {Panés J and Colombel JF and D'Haens GR and Schreiber S and Panaccione R and Peyrin-Biroulet L and Loftus EV Jr and Danese S and Tanida S and Okuyama Y and Louis E and Armuzzi A and Ferrante M and Vogelsang H and Hibi T and Watanabe M and Lefebvre J and Finney-Hayward T and Sanchez Gonzalez Y and Doan TT and Mostafa NM and Ikeda K and Xie W and Huang B and Petersson J and Kalabic J and Robinson AM and Sandborn WJ},
  year = {2022},
  journal = {Gastroenterology},
  doi = {10.1053/j.gastro.2022.02.033},
  url = {https://doi.org/10.1053/j.gastro.2022.02.033}
}

RIS

TY  - JOUR
TI  - Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.
AU  - Panés J
AU  - Colombel JF
AU  - D'Haens GR
AU  - Schreiber S
AU  - Panaccione R
AU  - Peyrin-Biroulet L
AU  - Loftus EV Jr
AU  - Danese S
AU  - Tanida S
AU  - Okuyama Y
AU  - Louis E
AU  - Armuzzi A
AU  - Ferrante M
AU  - Vogelsang H
AU  - Hibi T
AU  - Watanabe M
AU  - Lefebvre J
AU  - Finney-Hayward T
AU  - Sanchez Gonzalez Y
AU  - Doan TT
AU  - Mostafa NM
AU  - Ikeda K
AU  - Xie W
AU  - Huang B
AU  - Petersson J
AU  - Kalabic J
AU  - Robinson AM
AU  - Sandborn WJ
PY  - 2022
JO  - Gastroenterology
DO  - 10.1053/j.gastro.2022.02.033
UR  - https://doi.org/10.1053/j.gastro.2022.02.033
ER  -

APA

J, P., JF, C., GR, D., S, S., R, P., L, P., Jr, L. E., S, D., S, T., Y, O., E, L., A, A., M, F., H, V., T, H., M, W., J, L., T, F., Y, S. G., TT, D., NM, M., K, I., W, X., B, H., J, P., J, K., AM, R., & WJ, S. (2022). Higher vs Standard Adalimumab Induction and Maintenance Dosing Regimens for Treatment of Ulcerative Colitis: SERENE UC Trial Results.. Gastroenterology. https://doi.org/10.1053/j.gastro.2022.02.033

Source records

pubmed · retrieved 2026-09-26T07:19:07.048Z